Kypha
Kypha is a St. Louis-based bioscience company developing diagnostic technologies to improve the way autoimmune, inflammatory and immunologic disorders are monitored and treated. The company is currently advancing its lead product, the Comp ActTM Test, toward regulatory clearance and market launch. Comp Act is a rapid, point-of-care test designed to accurately measure immune activity and inflammation in real time, thereby enabling clinicians to make earlier, more objective treatment decisions.